Limited sampling models for simultaneous estimation of the pharmacokinetics of irinotecan and its active metabolite SN-38. (Q52876917)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 1995

edit

Language	Label	Description	Also known as
English	Limited sampling models for simultaneous estimation of the pharmacokinetics of irinotecan and its active metabolite SN-38.	scientific article published in January 1995

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7554037

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7554037

title

Limited sampling models for simultaneous estimation of the pharmacokinetics of irinotecan and its active metabolite SN-38. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7554037

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7554037

main subject

irinotecan

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

G G Chabot

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7554037

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7554037

publication date

1 January 1995

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7554037

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7554037

published in

Cancer Chemotherapy and Pharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7554037

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7554037

volume

36

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7554037

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7554037

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7554037

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7554037

page(s)

463-472

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7554037

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7554037

cites work

Limited sampling models for topotecan pharmacokinetics

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limited sampling models for amonafide (NSC 308847) pharmacokinetics

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Camptothecin effects on DNA synthesis in murine leukemia cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacokinetic trial of weekly CPT-11

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA topoisomerase poisons as antitumor drugs

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical study of CPT-11. Research group of CPT-11

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Camptothecin analog (CPT-11)-sensitive human pancreatic tumor cell line QGP-1N shows resistance to SN-38, an active metabolite of CPT-11.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishment of a camptothecin analogue (CPT-11)-resistant cell line of human non-small cell lung cancer: characterization and mechanism of resistance

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothec in, a novel water-soluble derivative of camptothecin, against murine tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limited sampling model for vinblastine pharmacokinetics

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhi

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential modifications of topoisomerase I activity in a camptothecin-resistant cell line established by progressive adaptation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The current status of camptothecin analogues as antitumor agents

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA topoisomerases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Some suggestions for measuring predictive performance

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A limited sampling strategy for cyclophosphamide pharmacokinetics.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I Study and Pharmacokinetics of CPT-11 With 5-Day Continuous Infusion

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in cancer patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Camptothecin overcomes MDR1-mediated resistance in human KB carcinoma cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trials with the topoisomerase I inhibitors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of spontaneous and experimental metastasis by a new derivative of camptothecin, CPT-11, in mice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7554037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S002800050350

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7554037

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7554037

PubMed publication ID

7554037

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7554037

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7554037

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52876917&oldid=2144657796"